May 15, 2023

Growing collaborations, partnerships in Singapore

U-M President Santa Ono led a multi-disciplinary delegation to Singapore to launch new institutional agreements with the country's leading academic medical center and cancer institute.

National Univ of Singapore MOU signing
Signing a new institutional agreement with the National University of Singapore. From left: Rogel Cancer Director Eric Fearon; UMMS Senior Associate Dean Joseph Kolars; U-M President Santa Ono; NUS Vice Dean for Research Chng Wee Joo; and Tan Ker Kan, Vice Chairman of Medical Board for Research, at the affiliated National University Hospital.

University of Michigan and Michigan Medicine leaders are expanding international partnerships in Singapore.

A pair of new institutional agreements formalize collaborations with the National University of Singapore (NUS) and its affiliated hospital, as well as the National Cancer Centre of Singapore.

U-M President Santo Ono this month led a delegation of leaders to Singapore including UMMS Senior Associate Dean Joseph Kolars, Rogel Cancer Center Director Eric Fearon, and other faculty to launch the partnership, which is expected create opportunities for joint research, trainee and student exchange, and more.

“This unique collaboration connects our U-M and Michigan Medicine community with Singapore’s most prestigious public research university and the leading cancer center in South East Asia,” said Kolars, MD, MACP. “Our complementary strengths and shared values herald a meaningful partnership that will drive innovation in healthcare and beyond.”

U-M faculty on hand for the early collaboration discussions included Computational Medicine and Bioinformatics Chair Brian Athey; Professor Engineering and Computer Science and Vice Provost for Engaged Learning Valeria Bertacco; and F. DuBois Bowman, Dean of the School of Public Health.

Founded in 1905, the National University of Singapore comprises 16 colleges and schools as well as 35 research institutes and centers across three campuses. Its medical school is considered the region’s best, and its affiliated National University Hospital is the only public and not-for-profit hospital in Singapore to provide care for adults, women and children under one roof.

Part of the large Singapore Health Services network, the National Cancer Centre of Singapore (NCCS) is the country’s leading tertiary cancer center, providing a range of medical, educational and research activities within one institution. NCCS treats an estimated 70% of all public-sector institutions’ cancer patients in Singapore.

Earlier this year, NCCS moved into a new, state-of-the-art facility bringing clinical and research spaces under a single roof. Core research infrastructure includes a genetic microarray system, flow cytometry, confocal microscopy, DNA sequencing, and more.

Signing an institutional agreement with the National Cancer Centre of Singapore (NCCS). NCCS leadership from left: Deputy Chief Executive Officer for clinical operations Lim Soon Thye; NCCS Chief Executive Officer William Hwang; and Ivy Ng, Group Chief Executive Officer for Singapore Health Services.